Status:

COMPLETED

Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population

Lead Sponsor:

Cardiovascular Academy Society, Turkey

Conditions:

Acute Coronary Syndrome

Myocardial Infarction

Eligibility:

All Genders

18-90 years

Brief Summary

The objective of this study is to analyze the Demographics, Clinical Profiles, Management, in-Hospital and Long-Term Outcomes of Patients with Acute Coronary Syndrome Syndrome And Myocardial Infarctio...

Detailed Description

Acute coronary syndrome is leading causes of death worldwide. Although, \>90% of these patients had of culprit coronary lesion, a significant proportion of them had no any angiographic evidence of obs...

Eligibility Criteria

Inclusion

  • Patients older than 18 years
  • Evidence of an MI as defined any one of the following criteria:
  • Detection of a rise and/or fall of cardiac biomarker values \[preferably cardiac troponin (cTn)\] with at least one value above the 99th percentile upper reference limit (URL) and with at least one of the following:
  • i. Symptoms of ischaemia. ii. New or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB).
  • iii. Development of pathological Q waves in the ECG. iv. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.
  • v. Identification of an intracoronary thrombus by angiography.
  • Invasive diagnostic coronary angiography (IDCA) findings to allow determination of the presence /absence of obstructive coronary artery disease
  • Signed informed consent form to trial participation

Exclusion

  • Inability/Refused to provide informed consent
  • Age below 18 years
  • Patients with unstable angina pectoris (ACS without increase and/or decrease of a cardiac biomarker, preferably high-sensitivity cardiac troponin, with at least one value above the 99th percentile of the upper reference limit)
  • Patients refused invasive diagnostic coronary angiography
  • Myocardial infarction associated with revascularization procedures

Key Trial Info

Start Date :

March 5 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 15 2018

Estimated Enrollment :

16026 Patients enrolled

Trial Details

Trial ID

NCT03364387

Start Date

March 5 2018

End Date

June 15 2018

Last Update

July 24 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emin Alioğlu

Izmir, Turkey (Türkiye)